Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiang Y Lim

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Cardiovascular Research|April 7, 2020
Sustained subcutaneous delivery of secretome of human cardiac stem cells promotes cardiac repair following myocardial infarctionAndrew R Kompa, David W Greening, Anne M Kong, et al.
Cardiovascular Research|February 12, 2021
Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heartDarnel Prakoso, Shiang Y Lim, Jeffrey R Erickson, et al.
Cell Death Discovery|March 14, 2018
Mitochondrial fission protein Drp1 inhibition promotes cardiac mesodermal differentiation of human pluripotent stem cellsAshfaqul Hoque, Priyadharshini Sivakumaran, Simon T Bond, et al.
Aging|June 1, 2017
Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiencyDuncan E Crombie, Claire L Curl, Antonia Ja Raaijmakers, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Friedreich ataxia transcriptomic dysregulation and identification of cell type-specific biomarkers: A systematic review and meta-analysisMarnie L Maddock, Sara Miellet, Anjila Dongol, et al.
Cardiovascular Research|January 2, 2021
Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fissionSiavash Beikoghli Kalkhoran, Janos Kriston-Vizi, Sauri Hernandez-Resendiz, et al.
Particle and Fibre Toxicology|May 9, 2020
Amorphous SiO2 nanoparticles promote cardiac dysfunction via the opening of the mitochondrial permeability transition pore in rat heart and human cardiomyocytesOmar Lozano, Christian Silva-Platas, Héctor Chapoy-Villanueva, et al.
The FEBS Journal|April 29, 2026
Long-read sequencing-based atlas of tissue-specific expression of DNM1L transcript variantsFeng Yan, Jafar S Jabbari, Naomi X L Ling, et al.
Cell Death & Disease|June 22, 2026
Frataxin deficiency drives cardiac dysfunction and transcriptional dysregulation in Friedreich ataxia iPSC modelJarmon G Lees, Haoxiang Zhang, Lebei Jiao, et al.
Stem Cell Research & Therapy|December 5, 2025
Device encapsulated MSCs for adaptive secretome therapy to effectively target ischaemic heart injuryAndrew R Kompa, David W Greening, Jarmon G Lees, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Cardiovascular Research|April 7, 2020
Sustained subcutaneous delivery of secretome of human cardiac stem cells promotes cardiac repair following myocardial infarctionAndrew R Kompa, David W Greening, Anne M Kong, et al.
Cardiovascular Research|February 12, 2021
Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heartDarnel Prakoso, Shiang Y Lim, Jeffrey R Erickson, et al.
Cell Death Discovery|March 14, 2018
Mitochondrial fission protein Drp1 inhibition promotes cardiac mesodermal differentiation of human pluripotent stem cellsAshfaqul Hoque, Priyadharshini Sivakumaran, Simon T Bond, et al.
Aging|June 1, 2017
Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiencyDuncan E Crombie, Claire L Curl, Antonia Ja Raaijmakers, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Friedreich ataxia transcriptomic dysregulation and identification of cell type-specific biomarkers: A systematic review and meta-analysisMarnie L Maddock, Sara Miellet, Anjila Dongol, et al.
Cardiovascular Research|January 2, 2021
Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fissionSiavash Beikoghli Kalkhoran, Janos Kriston-Vizi, Sauri Hernandez-Resendiz, et al.
Particle and Fibre Toxicology|May 9, 2020
Amorphous SiO2 nanoparticles promote cardiac dysfunction via the opening of the mitochondrial permeability transition pore in rat heart and human cardiomyocytesOmar Lozano, Christian Silva-Platas, Héctor Chapoy-Villanueva, et al.
The FEBS Journal|April 29, 2026
Long-read sequencing-based atlas of tissue-specific expression of DNM1L transcript variantsFeng Yan, Jafar S Jabbari, Naomi X L Ling, et al.
Cell Death & Disease|June 22, 2026
Frataxin deficiency drives cardiac dysfunction and transcriptional dysregulation in Friedreich ataxia iPSC modelJarmon G Lees, Haoxiang Zhang, Lebei Jiao, et al.
Stem Cell Research & Therapy|December 5, 2025
Device encapsulated MSCs for adaptive secretome therapy to effectively target ischaemic heart injuryAndrew R Kompa, David W Greening, Jarmon G Lees, et al.
Pageof 9